Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-TNF-α Antibody Therapies in Autoimmune Diseases
Kokona Chatzantoni, Αthanasia Mouzaki
Current Topics in Medicinal Chemistry (2006) Vol. 6, Iss. 16, pp. 1707-1714
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
Dan-in Jang, A-Hyeon Lee, Hye-Yoon Shin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2719-2719
Open Access | Times Cited: 1017
Exploration of the medical periodic table: towards new targets
Nicolas P. E. Barry, Peter J. Sadler
Chemical Communications (2013) Vol. 49, Iss. 45, pp. 5106-5106
Open Access | Times Cited: 680
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Deok-Hoon Kong, Young Kim, Mi Kyung Kim, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1057-1057
Open Access | Times Cited: 566
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
Ping Li, Ying Zheng, Xin Chen
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 300
Iridium(iii) complexes as therapeutic and bioimaging reagents for cellular applications
Kenneth Kam‐Wing Lo, Kenneth Yin Zhang
RSC Advances (2012) Vol. 2, Iss. 32, pp. 12069-12069
Closed Access | Times Cited: 213
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
Alexandra Schnell, Lloyd Bod, Asaf Madi, et al.
Cell Research (2020) Vol. 30, Iss. 4, pp. 285-299
Open Access | Times Cited: 175
Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review
Jaume Alijotas‐Reig, Enrique Esteve‐Valverde, Ariadna Anunciación-Llunell, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 675-675
Open Access | Times Cited: 70
A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Chung‐Hang Leung, Hai‐Jing Zhong, Hui Yang, et al.
Angewandte Chemie (2012) Vol. 124, Iss. 36, pp. 9144-9148
Closed Access | Times Cited: 143
Structure‐Based Discovery of Natural‐Product‐like TNF‐α Inhibitors
Daniel Shiu‐Hin Chan, Ho‐Man Lee, Fang Yang, et al.
Angewandte Chemie International Edition (2010) Vol. 49, Iss. 16, pp. 2860-2864
Open Access | Times Cited: 114
Critical Role of MARCO in Crystalline Silica–Induced Pulmonary Inflammation
Sheetal A. Thakur, Celine A. Beamer, Christopher T. Migliaccio, et al.
Toxicological Sciences (2009) Vol. 108, Iss. 2, pp. 462-471
Open Access | Times Cited: 100
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?
Ilse Van Brussel, Wai Ping Lee, Miche Rombouts, et al.
Autoimmunity Reviews (2013) Vol. 13, Iss. 2, pp. 138-150
Closed Access | Times Cited: 90
SERS-based monitoring of the intracellular pH in endothelial cells: the influence of the extracellular environment and tumour necrosis factor-α
Aleksandra Jaworska, Lauren E. Jamieson, Kamilla Małek, et al.
The Analyst (2014) Vol. 140, Iss. 7, pp. 2321-2329
Open Access | Times Cited: 80
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders
Anna Balato, Emanuele Scala, Nicola Balato, et al.
Expert Opinion on Biological Therapy (2017), pp. 1-12
Closed Access | Times Cited: 67
Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
Xia Li, Mi Shao, Xiangjun Zeng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 49
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines
Valentina Andretto, Silvia Dusi, Serena Zilio, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115080-115080
Closed Access | Times Cited: 18
The histamine H4 receptor: A novel modulator of inflammatory and immune disorders
Mai Zhang, Robin L. Thurmond, Paul J. Dunford
Pharmacology & Therapeutics (2006) Vol. 113, Iss. 3, pp. 594-606
Closed Access | Times Cited: 108
Cytokines in Common Variable Immunodeficiency as Signs of Immune Dysregulation and Potential Therapeutic Targets – A Review of the Current Knowledge
Farnaz Najmi Varzaneh, Bärbel Keller, Susanne Unger, et al.
Journal of Clinical Immunology (2014) Vol. 34, Iss. 5, pp. 524-543
Closed Access | Times Cited: 60
Interleukin 4 inhibition as a potential therapeutic in pemphigus
Soheil Tavakolpour, Vahid Tavakolpour
Cytokine (2015) Vol. 77, pp. 189-195
Closed Access | Times Cited: 58
Bedside to bench: defining the immunopathogenesis of psoriatic arthritis
Arlene Bravo, Arthur Kavanaugh
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 11, pp. 645-656
Closed Access | Times Cited: 49
Exploring the role of cathepsin in rheumatoid arthritis
Tapan Behl, Swati Chadha, Aayush Sehgal, et al.
Saudi Journal of Biological Sciences (2021) Vol. 29, Iss. 1, pp. 402-410
Open Access | Times Cited: 37
Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor and systemic immune activation
Niki M. Moutsopoulos, G E Katsifis, Nikola Angelov, et al.
Annals of the Rheumatic Diseases (2008) Vol. 67, Iss. 10, pp. 1437-1443
Closed Access | Times Cited: 71
The Cytokine Basis of Cachexia and its Treatment: Are They Ready for Prime Time?
Shing‐Shing Yeh, Kimathi Blackwood, Michael W. Schuster
Journal of the American Medical Directors Association (2008) Vol. 9, Iss. 4, pp. 219-236
Closed Access | Times Cited: 64
Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
Matthias Bartneck, Jing Wang
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 42
The immune remodel: Weight loss-mediated inflammatory changes to obesity
Charles L. Phillips, Bernadette E. Grayson
Experimental Biology and Medicine (2020) Vol. 245, Iss. 2, pp. 109-121
Open Access | Times Cited: 37
Cross-sectional associations between serum PFASs and inflammatory biomarkers in a population exposed to AFFF-contaminated drinking water
Kelsey E. Barton, L. Zell-Baran, Jamie C. DeWitt, et al.
International Journal of Hygiene and Environmental Health (2022) Vol. 240, pp. 113905-113905
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top